What does Dr. Bassens en Dr. Serlet do?

Dr. Bassens en Dr. Serlet is a specialist medical practice in Aalter. Private Limited, started on 26 December 2018, 1 establishment.

What is the address of Dr. Bassens en Dr. Serlet?

The registered office of Dr. Bassens en Dr. Serlet is located at Blaktestraat 8, 9910 Aalter.

Is Dr. Bassens en Dr. Serlet still active?

Yes. According to the CBE (27 September 2026) Dr. Bassens en Dr. Serlet is active, legal situation “Normale toestand”, started on 26 December 2018.

Is Dr. Bassens en Dr. Serlet registered on Peppol?

Yes, Dr. Bassens en Dr. Serlet is registered on the Peppol network with ID 0208:0716856526.

What is the enterprise number of Dr. Bassens en Dr. Serlet?

The enterprise number of Dr. Bassens en Dr. Serlet is BE0716856526.

When was Dr. Bassens en Dr. Serlet founded?

Dr. Bassens en Dr. Serlet was founded on 26 December 2018.

Is Dr. Bassens en Dr. Serlet a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2018; 4 annual accounts filed, latest fiscal year 2025.

How much profit did Dr. Bassens en Dr. Serlet make in 2025?

Dr. Bassens en Dr. Serlet posted a profit after taxes of € 200,863 in financial year 2025.

What is the revenue of Dr. Bassens en Dr. Serlet?

As a small company, Dr. Bassens en Dr. Serlet is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 267,677.

Dr. Bassens en Dr. Serlet (Private Limited) - Aalter

Dossier Dr. Bassens en Dr. Serlet, printed on 27 September 2026 from databakkes.be/en/0716856526/dr-bassens-en-dr-serlet. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Bassens en Dr. Serlet from Aalter, company number BE0716856526, closed financial year 2025 with a result of € 200,863 after tax. For that financial year Dr. Bassens en Dr. Serlet recorded a gross margin of € 267,677 and equity of € 25,566. Compared with financial year 2024, the result moved from € 120,484 to € 200,863. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.

What it is worth Healthy

€ 25,566

▼ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 200,863

▲ 67% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 198,834

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 216,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 62,865

▲ € 62,445 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 56,340

€ 24,512 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 32,400

▲ 44% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 396,697 Gross margin 2022: € 396,697 First fiscal year in the series	€ 375,306 Gross margin 2023: € 375,306 ▼ 5% vs 2022 (€ 396,697) Unfavourable step	€ 149,632 Gross margin 2024: € 149,632 ▼ 60% vs 2023 (€ 375,306) Unfavourable step	€ 267,677 Gross margin 2025: € 267,677 ▲ 79% vs 2024 (€ 149,632) Favourable step	▲ 79%
Profit after taxes	€ 293,849 Profit after taxes 2022: € 293,849 First fiscal year in the series	€ 277,871 Profit after taxes 2023: € 277,871 ▼ 5% vs 2022 (€ 293,849) Unfavourable step	€ 120,484 Profit after taxes 2024: € 120,484 ▼ 57% vs 2023 (€ 277,871) Unfavourable step	€ 200,863 Profit after taxes 2025: € 200,863 ▲ 67% vs 2024 (€ 120,484) Favourable step	▲ 67%
Equity	€ 676,468 Equity 2022: € 676,468 First fiscal year in the series	€ 70,219 Equity 2023: € 70,219 ▼ 90% vs 2022 (€ 676,468) Unfavourable step	€ 40,703 Equity 2024: € 40,703 ▼ 42% vs 2023 (€ 70,219) Unfavourable step	€ 25,566 Equity 2025: € 25,566 ▼ 37% vs 2024 (€ 40,703) Unfavourable step	▼ 37%
Total debts	€ 43,480 Total debts 2022: € 43,480 First fiscal year in the series	€ 308,333 Total debts 2023: € 308,333 ▲ € 264,854 vs 2022 (€ 43,480) Unfavourable step	€ 174,230 Total debts 2024: € 174,230 ▼ 43% vs 2023 (€ 308,333) Favourable step	€ 268,951 Total debts 2025: € 268,951 ▲ 54% vs 2024 (€ 174,230) Unfavourable step	▲ 54%
Cash	€ 647,958 Cash 2022: € 647,958 First fiscal year in the series	€ 287,439 Cash 2023: € 287,439 ▼ 56% vs 2022 (€ 647,958) Unfavourable step	€ 172,376 Cash 2024: € 172,376 ▼ 40% vs 2023 (€ 287,439) Unfavourable step	€ 198,834 Cash 2025: € 198,834 ▲ 15% vs 2024 (€ 172,376) Favourable step	▲ 15%
Retained profit	€ 670,218 Retained profit 2022: € 670,218 First fiscal year in the series	€ 45,219 Retained profit 2023: € 45,219 ▼ 93% vs 2022 (€ 670,218) Unfavourable step	€ 15,703 Retained profit 2024: € 15,703 ▼ 65% vs 2023 (€ 45,219) Unfavourable step	€ 566 Retained profit 2025: € 566 ▼ 96% vs 2024 (€ 15,703) Unfavourable step	▼ 96%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 902,870 Dividend 2023: € 902,870 Unchanged (€ 0) Unchanged	€ 150,000 Dividend 2024: € 150,000 ▼ 83% vs 2023 (€ 902,870) Unchanged	€ 216,000 Dividend 2025: € 216,000 ▲ 44% vs 2024 (€ 150,000) Unchanged	▲ 44%
Bank debt	€ 20,983 Bank debt 2022: € 20,983 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 20,983) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 56,340 Bank debt 2025: € 56,340 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 719,947 Balance sheet total 2022: € 719,947 First fiscal year in the series	€ 378,552 Balance sheet total 2023: € 378,552 ▼ 47% vs 2022 (€ 719,947) Unchanged	€ 214,933 Balance sheet total 2024: € 214,933 ▼ 43% vs 2023 (€ 378,552) Unchanged	€ 294,517 Balance sheet total 2025: € 294,517 ▲ 37% vs 2024 (€ 214,933) Unchanged	▲ 37%

Key figures of Dr. Bassens en Dr. Serlet, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Dr. Bassens en Dr. Serlet?

What happened at Dr. Bassens en Dr. Serlet in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 14, 2026 New annual accounts for financial year 2025: profit of € 200,863 (▲ 67% vs 2024). Source: NBB ↗
Jan 1, 2019 New establishment in Aalter. KBO
Dec 26, 2018 Start of the company according to the CBE. KBO

In short

From € 293,849 profit in 2022 to € 200,863 profit in 2025.

Paid € 278,376 in corporate taxes since 2022.

Best year ever: 2022, with € 293,849 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Bassens en Dr. Serlet? We notify you, reason included.

Follow Dr. Bassens en Dr. Serlet

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Blaktestraat 8

9910 Aalter

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0716.856.526

VAT number

BE 0716.856.526

Registered office

Blaktestraat 8, 9910 Aalter

Names & denominations

Dr. Bassens en Dr. Serlet

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 December 2018

Peppol

Active · Active since 8 Oct 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗